Efficacy of krypton laser photodynamic therapy for oral mucosa dysplasia in 9,10‑dimethyl‑1,2‑benzanthracene‑treated hamsters

  • Authors:
    • Lingyue Shen
    • Qing Xu
    • Pingping Li
    • Guoyu Zhou
  • View Affiliations

  • Published online on: August 30, 2013     https://doi.org/10.3892/ol.2013.1554
  • Pages: 1358-1362
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study aimed to evaluate the efficacy of krypton laser photodynamic therapy (PDT) with PsD‑007 for the treatment of oral mucosa dysplasia in 9,10‑dimethyl‑1,2‑benzanthracene (DMBA)‑treated hamsters. A DMBA‑induced hamster cheek pouch model of precancerous lesions was created and the resultant 25 hamsters were divided into five groups. The right side was treated with PDT and the left side was used as the positive control. Following systemic anesthesia, an incision was made in the groin area to expose the femoral vein. PsD‑007 was administered intravenously through the femoral vein. Various doses of photosensitizer were used to treat groups A‑E. Subsequent to closing the incision, the right side of the buccal mucosa was irradiated with light using the krypton laser at a wavelength of 413 nm, a power density of 150 mW/cm2 and an irradiation time of 20 min. At six weeks post‑surgery, the response was analyzed using histological examinations of the buccal pouch mucosa. A total of 24 hamsters completed the six‑week observation period, as one hamster from group C died in the second week following the PDT. Of all 24 irradiated sides, 15 formed normal mucosal tissues and nine demonstrated mild dysplasia. Of the total control sides, six developed moderate dysplasia, five developed severe dysplasia and 13 progressed to carcinoma in situ or squamous cell carcinoma (SCC). The results revealed a significant difference between the two sides (P<0.01) and the various doses of the PsD‑007 groups. When the PsD‑007 dose was >10 mg/kg, there was no statistical difference (P>0.05). PsD‑007‑mediated krypton laser PDT is effective for the treatment of oral mucosa dysplasia in hamsters.
View Figures
View References

Related Articles

Journal Cover

November 2013
Volume 6 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Shen L, Xu Q, Li P and Zhou G: Efficacy of krypton laser photodynamic therapy for oral mucosa dysplasia in 9,10‑dimethyl‑1,2‑benzanthracene‑treated hamsters. Oncol Lett 6: 1358-1362, 2013
APA
Shen, L., Xu, Q., Li, P., & Zhou, G. (2013). Efficacy of krypton laser photodynamic therapy for oral mucosa dysplasia in 9,10‑dimethyl‑1,2‑benzanthracene‑treated hamsters. Oncology Letters, 6, 1358-1362. https://doi.org/10.3892/ol.2013.1554
MLA
Shen, L., Xu, Q., Li, P., Zhou, G."Efficacy of krypton laser photodynamic therapy for oral mucosa dysplasia in 9,10‑dimethyl‑1,2‑benzanthracene‑treated hamsters". Oncology Letters 6.5 (2013): 1358-1362.
Chicago
Shen, L., Xu, Q., Li, P., Zhou, G."Efficacy of krypton laser photodynamic therapy for oral mucosa dysplasia in 9,10‑dimethyl‑1,2‑benzanthracene‑treated hamsters". Oncology Letters 6, no. 5 (2013): 1358-1362. https://doi.org/10.3892/ol.2013.1554